Pentixapharm Holding AG is a Germany-based clinical-stage radiopharmaceutical development company. The Company focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. It is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Back to dashboard
Company Information
About this company
Key people
Andreas Eckert
Chairman of the Supervisory Board
Hakim Bouterfa
Chief Executive Officer, Member of the Management Board
Harald Hasselmann
Deputy Chairman of the Supervisory Board
Jens Giltsch
Member of the Supervisory Board
Ken Herrmann
Member of the Supervisory Board
Click to see more
Key facts
- Shares in issue35.82m
- EPICPTP
- ISINDE000A40AEG0
- LocationGermany
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€66.26m
- Employees38
- ExchangeXETRA
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.